Isentress Sales Data
| Rank 61 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Isentress U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 61 ( 1) |
$248,924 | 0.72% | 263 | -0.38% |
| Q3 2013 | 60 (3) |
$247,145 | -2.06% | 264 | -3.30% |
| Q2 2013 | 57 ( 2) |
$252,347 | 3.58% | 273 | 1.49% |
| Q1 2013 | 59 (1) |
$243,636 | 2.00% | 269 | -0.37% |
| Q4 2012 | 60 (4) |
$238,849 | 2.34% | 270 | 3.45% |
| Q3 2012 | 64 (4) |
$233,391 | 2.58% | 261 | 2.76% |
| Q2 2012 | 68 (9) |
$227,514 | 7.56% | 254 | 4.10% |
| Q1 2012 | 77 (1) |
$211,526 | 2.46% | 244 | 2.09% |
| Q4 2011 | 78 | $206,451 | 6.07% | 239 | 6.22% |
| Q3 2011 | 78 (6) |
$194,642 | 6.05% | 225 | 2.74% |
| Q2 2011 | 84 (16) |
$183,544 | 7.95% | 219 | 7.88% |
| Q1 2011 | 100 | $170,024 | n/a | 203 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
